Dusa Pharmaceuticals, Inc. (DUSA) Tops Q3 EPS by 5c

November 10, 2011 6:33 AM EST
Dusa Pharmaceuticals, Inc. (NASDAQ: DUSA) reported Q3 EPS of $0.05, $0.05 better than the analyst estimate of $0.00. Revenue for the quarter came in at $9.4 million versus the consensus estimate of $8.79 million.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings